Effect of Cuzhi liquid on learning and memory dysfunction in a mouse model of Alzheimer's disease

被引:0
|
作者
Liu Lijuan [1 ]
Yu Chen [2 ]
Liu Junbao [3 ]
机构
[1] Pharmacy Department, People's Hospital of Henan Province, People's Hospital of Zhengzhou University
[2] Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University
[3] Traditional Chinese Medicine Department, People's Hospital of Henan Province, People's Hospital of Zhengzhou University
关键词
Alzheimer disease; Learning; Memory; Acetylcholinesterase; Oxidoreductases; Nitric ox ide; Malondialdehyde; Amyloidogenic proteins; Lymphoma; B-cell; Cuzhi liquid;
D O I
暂无
中图分类号
R285.5 [中药实验药理];
学科分类号
1008 ;
摘要
OBJECTIVE: To examine the effects of Cuzhi liquid on learning and memory abilities in a mouse model of Alzheimer’s disease(AD).METHODS: One hundred mice were divided into the normal, AD model, piracetam group, Cuzhi liquid low dose and Cuzhi liquid high dose, each group 20 mice. The AD mouse model was induced by daily intraperitoneal injection of D-galactose and sodium nitrite. AD mice then received intragastric administration of piracetam or Cuzhi liquid for60 d, and changes in learning and memory abilities were assessed using the water maze test. The activity of acetylcholinsterase(AchE) and monamine oxidase(MAO), and the levels of nitrogen monoxidum(NO) and malonaldehyde(MDA), were measured in brain tissues. Amyloid protein deposition was assessed by methyl violet staining, and B-cell lymphoma-2(Bcl-2) expression in the hippocampal cornus ammonis 1 region was detected by immunohistochemistry.RESULTS: In the water maze test, the escape latency of the model group was longer than that of the normal group(P < 0.01). The escape latency of the three using drug treatment groups was significantly less than that of the normal group(P < 0.05). The activity of AchE and MAO, and the levels of NO and MDA, in the brain of the model group were significantly higher than that of the normal group(P <0.01), but significantly reduced in the three drug treatment groups compared with the model group(P < 0.05). AchE activity showed a greater reduction in the two Cuzhi liquid groups compared with the piracetam group(P < 0.01), to levels similar to the normal group. There were no differences in MAO activity or NO levels between the three drug treatment groups, while MDA levels were reduced more in the high-dose Cuzhi liquid group compared with the other treatment groups(P < 0.01). Hippocampal Bcl-2 expression was significantly reduced in the model group compared with the normal group(P < 0.01), but significantly improved in the three drug treatment groups(P < 0.05). The high-dose Cuzhi liquid group showed a significantly greater recovery in Bcl-2 expression compared with the other treatment groups.CONCLUSION: Cuzhi liquid can improve learning and memory impairment in an AD mouse model.The mechanism of action may relate to reduced AchE and MAO activity, and reduced NO and MDA levels, in the brain, and improved Bcl-2 expression,an inhibitor of apoptosis.
引用
收藏
页码:890 / 895
页数:6
相关论文
共 50 条
  • [1] Effect of Cuzhi liquid on learning and memory dysfunction in a mouse model of Alzheimer's disease
    Liu Lijuan
    Yu Chen
    Liu Junbao
    [J]. JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2018, 38 (06) : 890 - 895
  • [2] Learning and memory deficits in a novel mouse model of Alzheimer's disease
    Murnane, Kevin
    Daphney, Cedrick
    [J]. FASEB JOURNAL, 2017, 31
  • [3] Neuroprotective effect of formononetin in ameliorating learning and memory impairment in mouse model of Alzheimer's disease
    Fei, Hong-Xin
    Zhang, Ying-Bo
    Liu, Ting
    Zhang, Xiao-Jie
    Wu, Shu-Liang
    [J]. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2018, 82 (01) : 57 - 64
  • [4] Endothelial dysfunction in a mouse model of Alzheimer's disease
    Pereira, A. M.
    Carvalho, C.
    Fernandes, R.
    Moreira, P. I.
    Seica, R. M.
    Sena, C. M.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2013, 43 : 98 - 98
  • [5] Synergistic Exacerbation of Mitochondrial and Synaptic Dysfunction and Resultant Learning and Memory Deficit in a Mouse Model of Diabetic Alzheimer's Disease
    Wang, Yongfu
    Wu, Long
    Li, Jianping
    Fang, Du
    Zhong, Changjia
    Chen, John Xi
    Yan, Shirley ShiDu
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2015, 43 (02) : 451 - 463
  • [6] Measuring memory in a mouse model of Alzheimer's disease
    Routtenberg, A
    [J]. SCIENCE, 1997, 277 (5327) : 839 - 840
  • [7] The Effect of Metals on Spatial Memory in a Transgenic Mouse Model of Alzheimer's Disease
    Railey, Angela M.
    Groeber, Caitlin M.
    Flinn, Jane M.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2011, 24 (02) : 375 - 381
  • [8] Neuroprotective Effects of Spinosin on Recovery of Learning and Memory in a Mouse Model of Alzheimer's Disease
    Xu, Fanxing
    He, Bosai
    Xiao, Feng
    Yan, Tingxu
    Bi, Kaishun
    Jia, Ying
    Wang, Zhenzhong
    [J]. BIOMOLECULES & THERAPEUTICS, 2019, 27 (01) : 71 - 77
  • [9] Diagnosing learning and memory dysfunction in a neurodegenerative disease: The case of Alzheimer's disease
    Dalle, Ernest
    Nguele, Marc Olivier Ondoua
    Bayaga, Herve
    [J]. JOURNAL OF NEUROCHEMISTRY, 2022, 162 : 95 - 95
  • [10] Measuring memory in a mouse model of Alzheimer's disease - Response
    Hsiao, K
    Chapman, P
    Nilsen, S
    Eckman, C
    Harigaya, Y
    Younkin, S
    Yang, FS
    Cole, G
    [J]. SCIENCE, 1997, 277 (5327) : 840 - 841